Given the lack of stringent and uniform federal regulations, Boston's emergent biotech lab industry have the responsibility to ensure they are operating with the safety of their neighbors in mind.
The Boston University National Emerging Infectious Diseases Laboratories gained approval from the Massachusetts state government Friday to begin researching biosafety Level 3 and Level 4 pathogens, officials...
